FASTKD3
gene geneOn this page
Also known as MGC5297FLJ23274
Summary
FASTKD3 (FAST kinase domains 3, HGNC:28758) is a protein-coding gene on chromosome 5p15.31, encoding FAST kinase domain-containing protein 3, mitochondrial (Q14CZ7). Required for normal mitochondrial respiration.
This gene encodes a member of a small family of Fas-activated serine/threonine kinase domain (FASTKD) containing proteins that share an amino terminal mitochondrial targeting domain and multiple carboxy terminal FAST domains as well as a putative RNA-binding RAP domain. The members of this family are ubiquitously expressed and are generally most abundant in mitochondria-enriched tissues such as heart, skeletal muscle and brown-adipose tissue. Some members of this protein family may play a role in apoptosis. The protein encoded by this gene interacts with components of the mitochondrial respiratory and translation networks. A pseudogene of this gene is also present on chromosome 5. Alternative splicing results in multiple transcript variants.
Source: NCBI Gene 79072 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 87 total
- MANE Select transcript:
NM_024091
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28758 |
| Approved symbol | FASTKD3 |
| Name | FAST kinase domains 3 |
| Location | 5p15.31 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC5297, FLJ23274 |
| Ensembl gene | ENSG00000124279 |
| Ensembl biotype | protein_coding |
| OMIM | 617530 |
| Entrez | 79072 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 5 protein_coding, 2 protein_coding_CDS_not_defined, 2 nonsense_mediated_decay, 1 retained_intron
ENST00000264669, ENST00000282110, ENST00000504695, ENST00000507036, ENST00000507572, ENST00000511261, ENST00000513577, ENST00000513658, ENST00000870229, ENST00000966723
RefSeq mRNA: 1 — MANE Select: NM_024091
NM_024091
CCDS: CCDS3873
Canonical transcript exons
ENST00000264669 — 7 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001130855 | 7866646 | 7868196 |
| ENSE00001430975 | 7868979 | 7869031 |
| ENSE00001912408 | 7859159 | 7859539 |
| ENSE00003475392 | 7861149 | 7861263 |
| ENSE00003480766 | 7861583 | 7861652 |
| ENSE00003563585 | 7865898 | 7865983 |
| ENSE00003671756 | 7862823 | 7862997 |
Expression profiles
Bgee: expression breadth ubiquitous, 280 present calls, max score 93.15.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.8847 / max 111.9375, expressed in 1787 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 60868 | 10.5711 | 1787 |
| 60867 | 0.3137 | 94 |
Top tissues by expression
289 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| oocyte | CL:0000023 | 93.15 | gold quality |
| secondary oocyte | CL:0000655 | 92.74 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 89.24 | gold quality |
| jejunal mucosa | UBERON:0000399 | 88.26 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 87.87 | gold quality |
| right uterine tube | UBERON:0001302 | 87.51 | gold quality |
| nephron tubule | UBERON:0001231 | 87.23 | gold quality |
| colonic mucosa | UBERON:0000317 | 86.43 | gold quality |
| biceps brachii | UBERON:0001507 | 86.28 | gold quality |
| hair follicle | UBERON:0002073 | 86.27 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 86.20 | gold quality |
| metanephros cortex | UBERON:0010533 | 85.86 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 85.50 | gold quality |
| tibia | UBERON:0000979 | 85.48 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 85.44 | gold quality |
| right adrenal gland | UBERON:0001233 | 85.24 | gold quality |
| mucosa of transverse colon | UBERON:0004991 | 84.89 | gold quality |
| left adrenal gland | UBERON:0001234 | 84.81 | gold quality |
| ventricular zone | UBERON:0003053 | 84.56 | gold quality |
| calcaneal tendon | UBERON:0003701 | 84.54 | gold quality |
| gingival epithelium | UBERON:0001949 | 84.50 | gold quality |
| cortex of kidney | UBERON:0001225 | 84.46 | gold quality |
| metanephros | UBERON:0000081 | 84.37 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 84.31 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 84.28 | gold quality |
| rectum | UBERON:0001052 | 84.21 | gold quality |
| skeletal muscle tissue of biceps brachii | UBERON:0004502 | 84.19 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 84.09 | gold quality |
| duodenum | UBERON:0002114 | 84.03 | gold quality |
| adrenal cortex | UBERON:0001235 | 84.02 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.94 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
26 targeting FASTKD3, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-200B-3P | 100.00 | 73.31 | 2693 |
| HSA-MIR-200C-3P | 100.00 | 73.35 | 2685 |
| HSA-MIR-429 | 100.00 | 73.44 | 2698 |
| HSA-MIR-4775 | 99.98 | 75.00 | 6394 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-548N | 99.98 | 71.94 | 4170 |
| HSA-MIR-590-3P | 99.96 | 74.34 | 6478 |
| HSA-MIR-23A-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23B-3P | 99.95 | 74.24 | 3163 |
| HSA-MIR-23C | 99.95 | 73.92 | 3192 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-6875-3P | 99.82 | 70.26 | 2983 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-587 | 99.64 | 70.86 | 2611 |
| HSA-MIR-425-5P | 99.59 | 67.67 | 900 |
| HSA-MIR-3942-3P | 99.57 | 69.03 | 2854 |
| HSA-MIR-12123 | 99.52 | 71.79 | 2990 |
| HSA-MIR-4452 | 99.50 | 68.45 | 1493 |
| HSA-MIR-5683 | 99.36 | 68.59 | 2083 |
| HSA-MIR-5589-3P | 99.29 | 68.30 | 1443 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-5100 | 99.11 | 67.52 | 1098 |
| HSA-MIR-548L | 99.06 | 70.90 | 2560 |
| HSA-MIR-3117-5P | 99.04 | 67.93 | 618 |
| HSA-MIR-1288-5P | 98.85 | 67.01 | 734 |
Literature-anchored findings (GeneRIF, showing 3)
- these results introduce FASTKD3 as an essential component of mitochondrial respiration that may modulate energy balance in cells exposed to adverse conditions by functionally coupling mitochondrial protein synthesis to respiration. (PMID:20869947)
- FASTKD3 is required for efficient COX1 mRNA translation without altering mRNA levels, which results in a decrease in the steady-state levels of COX1 protein. (PMID:27789713)
- Despite the fact that proteins of the FASTK family FASTKD1-5 share the same domains, they exhibit various-sometimes opposing-functions in almost all steps of mitochondrial RNA metabolism. (PMID:29036396)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | fastkd3 | ENSDARG00000100440 |
| mus_musculus | Fastkd3 | ENSMUSG00000021532 |
| rattus_norvegicus | Fastkd3 | ENSRNOG00000027422 |
Paralogs (5): FASTKD2 (ENSG00000118246), TBRG4 (ENSG00000136270), FASTKD1 (ENSG00000138399), FASTK (ENSG00000164896), FASTKD5 (ENSG00000215251)
Protein
Protein identifiers
FAST kinase domain-containing protein 3, mitochondrial — Q14CZ7 (reviewed: Q14CZ7)
All UniProt accessions (5): D6RAR6, D6RB04, D6RC07, D6RHY4, Q14CZ7
UniProt curated annotations — full annotation on UniProt →
Function. Required for normal mitochondrial respiration. Increases steady-state levels and half-lives of a subset of mature mitochondrial mRNAs MT-ND2, MT-ND3, MT-CYTB, MT-CO2, and MT-ATP8/6. Promotes MT-CO1 mRNA translation and increases mitochondrial complex IV assembly and activity.
Subcellular location. Mitochondrion.
Tissue specificity. Expression detected in spleen, thymus, testis, ovary, colon, heart, smooth muscle, kidney, brain, lung, liver and white adipose tissue with highest expression in liver and thyroid.
Domain organisation. RAP domain is required for FASTKD3 function in mRNA stability and translation.
Similarity. Belongs to the FAST kinase family.
RefSeq proteins (1): NP_076996* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR010622 | FAST_Leu-rich | Domain |
| IPR013579 | FAST_2 | Domain |
| IPR013584 | RAP | Domain |
| IPR050870 | FAST_kinase | Family |
Pfam: PF06743, PF08368, PF08373
UniProt features (7 total): sequence variant 4, transit peptide 1, chain 1, domain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q14CZ7-F1 | 81.59 | 0.59 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 112 (showing top):
GSE45365_CD8A_DC_VS_CD11B_DC_IFNAR_KO_UP, GSE45365_NK_CELL_VS_CD8A_DC_MCMV_INFECTION_DN, GOBP_RESPIRATORY_CHAIN_COMPLEX_IV_ASSEMBLY, GOBP_REGULATION_OF_MRNA_CATABOLIC_PROCESS, MIDORIKAWA_AMPLIFIED_IN_LIVER_CANCER, GOBP_MITOCHONDRIAL_RESPIRATORY_CHAIN_COMPLEX_ASSEMBLY, GOBP_MACROMOLECULE_CATABOLIC_PROCESS, GOBP_MITOCHONDRIAL_TRANSLATION, MONNIER_POSTRADIATION_TUMOR_ESCAPE_UP, GOBP_CYTOCHROME_COMPLEX_ASSEMBLY, GOBP_TRANSLATION, GOBP_POST_TRANSCRIPTIONAL_REGULATION_OF_GENE_EXPRESSION, GOBP_REGULATION_OF_CATABOLIC_PROCESS, GOBP_MITOCHONDRIAL_RNA_PROCESSING, GOBP_MITOCHONDRIAL_RNA_METABOLIC_PROCESS
GO Biological Process (4): mitochondrial RNA processing (GO:0000963), mitochondrial respiratory chain complex IV assembly (GO:0033617), regulation of mitochondrial mRNA stability (GO:0044528), positive regulation of mitochondrial translation (GO:0070131)
GO Molecular Function (2): RNA binding (GO:0003723), protein binding (GO:0005515)
GO Cellular Component (4): nucleoplasm (GO:0005654), mitochondrion (GO:0005739), mitochondrial matrix (GO:0005759), ribonucleoprotein granule (GO:0035770)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitochondrion | 3 |
| mitochondrial RNA metabolic process | 1 |
| RNA processing | 1 |
| mitochondrial gene expression | 1 |
| respiratory chain complex IV assembly | 1 |
| mitochondrial respiratory chain complex assembly | 1 |
| regulation of mRNA stability | 1 |
| mitochondrial translation | 1 |
| positive regulation of translation | 1 |
| regulation of mitochondrial translation | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| nuclear lumen | 1 |
| cellular anatomical structure | 1 |
| cytoplasm | 1 |
| intracellular membrane-bounded organelle | 1 |
| intracellular organelle lumen | 1 |
| intracellular membraneless organelle | 1 |
| supramolecular complex | 1 |
Protein interactions and networks
STRING
2066 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| FASTKD3 | PTCD1 | O75127 | 802 |
| FASTKD3 | DHX30 | Q7L2E3 | 670 |
| FASTKD3 | MRPS31 | Q92665 | 651 |
| FASTKD3 | PNPT1 | Q8TCS8 | 621 |
| FASTKD3 | IARS2 | Q9NSE4 | 608 |
| FASTKD3 | MTO1 | Q9Y2Z2 | 602 |
| FASTKD3 | LRPPRC | P42704 | 600 |
| FASTKD3 | MRPS22 | P82650 | 599 |
| FASTKD3 | GFM1 | Q96RP9 | 589 |
| FASTKD3 | MTRR | Q9UBK8 | 558 |
| FASTKD3 | FASTKD2 | Q9NYY8 | 538 |
| FASTKD3 | TUFM | P49411 | 533 |
| FASTKD3 | AMZ1 | Q400G9 | 512 |
| FASTKD3 | TARS2 | Q9BW92 | 505 |
| FASTKD3 | CCDC57 | Q2TAC2 | 491 |
IntAct
55 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| FAM9B | FASTKD3 | psi-mi:“MI:0915”(physical association) | 0.670 |
| FASTKD3 | FAM9B | psi-mi:“MI:0915”(physical association) | 0.670 |
| FASTKD3 | MAGEA12 | psi-mi:“MI:0915”(physical association) | 0.560 |
| FASTKD3 | AGTRAP | psi-mi:“MI:0915”(physical association) | 0.560 |
| AGTRAP | FASTKD3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MAGEA12 | FASTKD3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| LAMP3 | METTL15 | psi-mi:“MI:0914”(association) | 0.530 |
| NPY2R | RTL8C | psi-mi:“MI:0914”(association) | 0.530 |
| SPACA1 | GOLIM4 | psi-mi:“MI:0914”(association) | 0.530 |
| TMEM9 | ESYT2 | psi-mi:“MI:0914”(association) | 0.530 |
| CXCR4 | TMEM120B | psi-mi:“MI:0914”(association) | 0.530 |
| VTN | HAT1 | psi-mi:“MI:0914”(association) | 0.530 |
| steC | SCD | psi-mi:“MI:0914”(association) | 0.460 |
| FASTKD3 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
| BSG | METTL15 | psi-mi:“MI:0914”(association) | 0.350 |
| SLAMF1 | RTCA | psi-mi:“MI:0914”(association) | 0.350 |
| VTN | HAT1 | psi-mi:“MI:0914”(association) | 0.350 |
| MUC20 | RAD51B | psi-mi:“MI:0914”(association) | 0.350 |
| M | psi-mi:“MI:0914”(association) | 0.350 | |
| M | TM9SF1 | psi-mi:“MI:0914”(association) | 0.350 |
| ATG16L1 | psi-mi:“MI:0914”(association) | 0.350 | |
| SPACA1 | ESYT2 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (149): FASTKD3 (Two-hybrid), FASTKD3 (Two-hybrid), FAM9B (Two-hybrid), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS), FASTKD3 (Affinity Capture-MS)
ESM2 similar proteins: A1A5P5, A1L2L5, A1Z9A8, B5DF07, O15091, P42704, Q07DV3, Q08CK1, Q0IHP3, Q14C51, Q14CX7, Q14CZ7, Q28C74, Q28DE0, Q2KI62, Q32LU7, Q32N55, Q32PI8, Q3SZ55, Q4R366, Q4R6I5, Q53R41, Q566X6, Q58CX2, Q5R503, Q5R8W8, Q5RFI6, Q5SGE0, Q5XIR8, Q5ZKK3, Q5ZLS8, Q68FN9, Q6AYP3, Q6DI86, Q6GQ66, Q6PB66, Q6QI44, Q7L8L6, Q7TMV3, Q7Z3E5
Diamond homologs: Q14CZ7, Q58CX2, Q68FN9, Q8BSN9, Q5M7V7, Q5R776, Q922E6, Q9NYY8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
87 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 59 |
| Likely benign | 13 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
756 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:7861143:CCGTA:C | donor_loss | 1.0000 |
| 5:7861144:CGTA:C | donor_loss | 1.0000 |
| 5:7861145:GTACC:G | donor_loss | 1.0000 |
| 5:7861146:TACC:T | donor_loss | 1.0000 |
| 5:7861147:A:AT | donor_loss | 1.0000 |
| 5:7861159:TGATA:T | donor_gain | 1.0000 |
| 5:7861259:CTATC:C | acceptor_gain | 1.0000 |
| 5:7861260:TATC:T | acceptor_gain | 1.0000 |
| 5:7861261:ATC:A | acceptor_gain | 1.0000 |
| 5:7861262:TC:T | acceptor_gain | 1.0000 |
| 5:7861263:CC:C | acceptor_gain | 1.0000 |
| 5:7861264:C:CC | acceptor_gain | 1.0000 |
| 5:7859538:ATC:A | acceptor_loss | 0.9900 |
| 5:7859540:C:CA | acceptor_loss | 0.9900 |
| 5:7859540:C:CC | acceptor_gain | 0.9900 |
| 5:7861147:A:AC | donor_gain | 0.9900 |
| 5:7861148:C:CC | donor_gain | 0.9900 |
| 5:7861264:C:T | acceptor_gain | 0.9900 |
| 5:7861271:A:AC | acceptor_gain | 0.9900 |
| 5:7861271:A:C | acceptor_gain | 0.9900 |
| 5:7861577:CTGTA:C | donor_loss | 0.9900 |
| 5:7861578:TGTAC:T | donor_loss | 0.9900 |
| 5:7861579:GTACC:G | donor_loss | 0.9900 |
| 5:7861580:TA:T | donor_loss | 0.9900 |
| 5:7861582:CCT:C | donor_loss | 0.9900 |
| 5:7861650:CAT:C | acceptor_gain | 0.9900 |
| 5:7861650:CATCT:C | acceptor_loss | 0.9800 |
| 5:7861652:TCTGG:T | acceptor_loss | 0.9800 |
| 5:7861653:C:T | acceptor_loss | 0.9800 |
| 5:7859537:GAT:G | acceptor_gain | 0.9700 |
AlphaMissense
4340 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 5:7861188:T:A | K615N | 0.988 |
| 5:7861188:T:G | K615N | 0.988 |
| 5:7861177:A:G | L619P | 0.986 |
| 5:7861258:G:T | A592E | 0.986 |
| 5:7862891:A:G | L544P | 0.975 |
| 5:7861230:A:C | F601L | 0.974 |
| 5:7861230:A:T | F601L | 0.974 |
| 5:7861232:A:G | F601L | 0.974 |
| 5:7861189:T:A | K615I | 0.972 |
| 5:7859484:A:G | L647S | 0.969 |
| 5:7861255:A:T | L593Q | 0.961 |
| 5:7861182:T:A | R617S | 0.957 |
| 5:7861182:T:G | R617S | 0.957 |
| 5:7862823:C:G | D567H | 0.957 |
| 5:7862860:A:C | F554L | 0.957 |
| 5:7862860:A:T | F554L | 0.957 |
| 5:7862862:A:G | F554L | 0.957 |
| 5:7861255:A:C | L593R | 0.954 |
| 5:7861163:A:C | Y624D | 0.953 |
| 5:7861255:A:G | L593P | 0.952 |
| 5:7862891:A:C | L544R | 0.946 |
| 5:7861177:A:T | L619Q | 0.944 |
| 5:7861643:A:C | I570S | 0.944 |
| 5:7867464:C:G | R207P | 0.943 |
| 5:7862891:A:T | L544Q | 0.942 |
| 5:7861643:A:G | I570T | 0.941 |
| 5:7861162:T:G | Y624S | 0.937 |
| 5:7862882:A:G | L547P | 0.936 |
| 5:7861189:T:G | K615T | 0.933 |
| 5:7861643:A:T | I570N | 0.932 |
dbSNP variants (sampled 300 via entrez): RS1000070228 (5:7868253 C>A,T), RS1000241404 (5:7870983 T>A,G), RS1000340924 (5:7864883 G>A,T), RS1000390070 (5:7865170 C>T), RS1000599722 (5:7861362 T>C), RS1000677622 (5:7866762 T>C), RS1000783122 (5:7859982 T>C,G), RS1000946491 (5:7868638 G>A,C), RS1001132397 (5:7866995 G>A), RS1002007394 (5:7868016 G>C), RS1002082729 (5:7865859 C>A,T), RS1002094701 (5:7870170 C>A), RS1002136732 (5:7866225 A>C), RS1002288590 (5:7859098 T>G), RS1002567430 (5:7860822 C>T)
Disease associations
OMIM: gene MIM:617530 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
PharmGKB clinical annotations
6 annotations.
| Variant | Type | Level | Drugs | Phenotypes |
|---|---|---|---|---|
| rs1801394 | Efficacy | 3 | sevoflurane | sedation |
| rs1801394 | Other | 3 | sevoflurane | |
| rs1801394 | Toxicity | 4 | methotrexate | Juvenile Rheumatoid Arthritis;Rheumatoid arthritis |
| rs2307116 | Other | 3 | sevoflurane | |
| rs2307116 | Efficacy | 3 | sevoflurane | |
| rs3733784 | Efficacy | 3 | sevoflurane |
PharmGKB variants
3 variants.
| Variant | Genes | Level | Score | #Clin annots | Drugs |
|---|---|---|---|---|---|
| rs1801394 | FASTKD3, MTRR | 3 | 4.75 | 6 | folic acid;vitamin b-complex;plain;methotrexate;sevoflurane |
| rs3733784 | FASTKD3, MTRR | 3 | 2.50 | 1 | sevoflurane |
| rs2307116 | FASTKD3, MTRR | 3 | 2.00 | 2 | sevoflurane |
CTD chemical–gene interactions
29 total (human), top 29 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | decreases expression, affects cotreatment, increases abundance, increases expression | 2 |
| Acetaminophen | decreases expression | 2 |
| Cyclosporine | decreases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| tris(1,3-dichloro-2-propyl)phosphate | decreases expression | 1 |
| manganese chloride | affects cotreatment, increases abundance, increases expression | 1 |
| potassium chromate(VI) | increases expression | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| ICG 001 | decreases expression | 1 |
| jinfukang | decreases expression | 1 |
| MT19c compound | increases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | decreases expression, increases abundance | 1 |
| Arsenic | affects cotreatment, increases abundance, increases expression | 1 |
| Diuron | decreases expression | 1 |
| Ethyl Methanesulfonate | decreases expression | 1 |
| Formaldehyde | decreases expression | 1 |
| Manganese | affects cotreatment, increases abundance, increases expression | 1 |
| Methyl Methanesulfonate | decreases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| Vanadates | decreases expression | 1 |
| Vitamin E | decreases expression | 1 |
| Aflatoxin B1 | decreases methylation | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | increases abundance, decreases expression | 1 |
Cellosaurus cell lines
4 cell lines: 4 cancer cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_C6Y4 | HAP1 FASTKD3-sKO | Cancer cell line | Male |
| CVCL_C6Y7 | HAP1 FASTKD3&4-dKO | Cancer cell line | Male |
| CVCL_SN21 | HAP1 FASTKD3 (-) 1 | Cancer cell line | Male |
| CVCL_XN69 | HAP1 FASTKD3 (-) 2 | Cancer cell line | Male |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.